<?xml version="1.0" encoding="UTF-8"?>
<p>Suggestive symptoms of CHIKV infection were reported by 51/168 (30%) of the patients in the group using bDMARDs and in 21/56 (37.5%) of the control group subjects (
 <italic>p</italic>=0.397), but serology for anti-CHIKV IgG was positive in only 42/168 (25%) and in 15/56 (27%) for the cases and controls, respectively, without a statistically significant difference between the groups (
 <italic>p</italic>=0.79).
</p>
